Illumina | ILMN - Des Atouts

Prix De L'Action
127.88
Variation Quotidienne
2.44 1.95%
Mensuellement
1.33%
Annuel
65.33%
Q2 Prévisions
125.14




Des Atouts Changement Date
Agilent USD 12.81B 86M 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.43B 224M 2025-12
Edwards Lifesciences USD 13.7B 425M 2025-12
Illumina USD 6.64B 467M 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Quidel USD 5.77B 94.2M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Standard Biotools USD 567.75M 28.12M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 5.08B 221.41M 2025-12